DSIP and Epithalon are supplied strictly as laboratory research materials. They are not approved, intended or authorised for human consumption or any therapeutic use in this context. This article is written for qualified researchers and is not medical advice.
Two routes to the same clock
Sleep and circadian rhythm are downstream of a great deal of biology, and different peptides intervene at very different points in that chain. DSIP and Epithalon are a good illustration. One is an acute neuromodulator with a plasma half-life measured in minutes; the other is a pineal-derived tetrapeptide studied for slow, chronic effects on the melatonin axis and on cellular ageing. They are sometimes mentioned in the same breath — and even studied in the same sleep-focused stack — but mechanistically they have very little in common. This comparison puts DSIP vs Epithalon side by side so the distinction is clear before you reach for either.
| DSIP | Epithalon | |
|---|---|---|
| Class / peptide type | Neuromodulatory neuropeptide (9 aa) | Pineal tetrapeptide (4 aa) |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | Ala-Glu-Asp-Gly (AEDG) |
| Primary mechanism | Delta-wave EEG induction; no single canonical receptor identified | Proposed telomerase activation; epigenetic / melatonin regulation |
| Half-life / duration | ~7–15 minutes (very short) | Not established; studied for chronic, cumulative effects |
| Main research focus | Sleep architecture, stress axis, opioid pathways | Telomere biology, longevity, circadian melatonin |
| Origin | Isolated 1974 (Monnier & Schoenenberger) | Derived from pineal epithalamin (Khavinson) |
| Regulatory status | Unapproved research compound | Unapproved research compound |
DSIP: the acute sleep-modulating neuropeptide
DSIP — Delta Sleep-Inducing Peptide — is a 9-amino-acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1974 by Monnier and Schoenenberger from the cerebral venous blood of sleeping rabbits. The name records the founding observation: infusion induced delta-wave, slow-wave EEG activity in research animals, an effect that has since been replicated across multiple species. What makes DSIP distinctive is how incompletely characterised it remains. No single dominant receptor or pathway has been identified; proteomic work has flagged DSIP-binding proteins but no canonical G-protein coupled receptor.
Its documented activity is broad rather than sharp. Beyond the delta-wave observation, published preclinical research describes modulation of opioid receptor pathways — DSIP antagonises some morphine-induced behaviours in rodents — and attenuation of HPA-axis corticosterone responses to stress. The overriding practical feature, though, is pharmacokinetic: a very short plasma half-life of roughly 7–15 minutes, consistent with rapid aminopeptidase degradation. That short window is the central challenge in translational DSIP work, and it frames the compound firmly as an acute, transient research probe. Researchers sourcing material can buy DSIP UK as a ≥99% purity reagent with a COA.
Epithalon: the pineal longevity tetrapeptide
Epithalon (also written Epitalon; sequence Ala-Glu-Asp-Gly, the AEDG peptide) sits at the opposite end of almost every axis. It is a synthetic tetrapeptide derived from epithalamin, a natural polypeptide extract of the pineal gland, developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Where DSIP is studied for what happens in the minutes after exposure, Epithalon is studied for slow, cumulative change — most prominently its proposed ability to activate telomerase in somatic cells and thereby influence telomere length, a key biomarker of cellular ageing.
The pineal origin also gives Epithalon a genuine circadian thread, which is where its research overlaps thematically with DSIP. Epithalamin is associated with melatonin regulation, and Epithalon has been studied for restorative effects on circadian melatonin amplitude in aged animal models. A 2020 Molecules paper from Khavinson's group reported that the AEDG peptide stimulates gene expression and protein synthesis during neurogenesis, proposing an epigenetic mechanism involving histone modification. An important caveat travels with all of this: much of the telomerase and epigenetic evidence originates with the peptide's developers, and independent replication in Western peer-reviewed journals is limited. You can review the full profile or buy Epithalon UK for research use.
What the differences mean in a research context
Read down the table and the two compounds barely occupy the same category. DSIP is a nine-residue neuropeptide acting acutely on sleep and stress circuitry with a half-life of minutes; Epithalon is a four-residue pineal peptide whose reported effects — telomerase, methylation shifts, melatonin amplitude — are chronic and cumulative and, by design, do not depend on sustained plasma levels. So although both touch the circadian theme, they touch it at different timescales: DSIP at the level of a single sleep episode, Epithalon at the level of the ageing pineal system that sets the rhythm in the first place.
The evidence bases differ in character too, and researchers should hold onto that. DSIP's founding EEG observation is well replicated even though its receptor-level mechanism is not resolved — a case of a robust effect with an unresolved mechanism. Epithalon's position is closer to the reverse: a proposed, mechanistically detailed story (telomerase activation, epigenetic modulation) that rests heavily on a single research lineage and awaits broad independent replication. Neither is an approved medicine anywhere; both are supplied only as research reagents. This is also why the two are sometimes studied together rather than as substitutes — an acute sleep-modulating peptide alongside a chronic circadian one, as noted on our DSIP knowledgebase page and its Epithalon counterpart.
The bottom line
DSIP and Epithalon share a circadian headline and almost nothing else. DSIP is the fast, transient neuropeptide for slow-wave-sleep and stress-axis research; Epithalon is the slow, pineal tetrapeptide for melatonin-timing and longevity research. Choose based on the question — an acute sleep-architecture probe or a chronic telomere/circadian one — not on the overlap in theme. For research-grade material, see our dedicated pages to buy DSIP UK and buy Epithalon UK, each ≥99% purity with a COA.